Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma

Journal of Translational Medicine

Volumn 6, Issue , 2008, Pages

  Li, Yu Hong ^a   Hu, Chun Fang ^a   Shao, Qiong ^a   Huang, Ma Yan ^a   Hou, Jing Hui ^a   Xie, Dan ^a   Zeng, Yi Xin ^a   Shao, Jian Yong ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; SURVIVIN; VASCULOTROPIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADOLESCENT; ADULT; ADVANCED CANCER; AGED; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; FEMALE; FOLLOW UP; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; NICK END LABELING; PREDICTION; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; BIOSYNTHESIS; CARCINOMA; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; NASOPHARYNX TUMOR; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CARCINOMA; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 40149093257     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-6-1     Document Type: Article

References (51)

1. Hay BA Wassarman DA Rubin GM Drosophila homologs of baculovirus inhibitor of apoptosis proteins function to block cell death Cell 1995, 83(7):1253-1262 10.1016/0092-8674(95)90150-7 8548811
2. Lu B Mu Y Cao C Zeng F Schneider S Tan J Price J Chen J Freeman M Hallahan DE Survivin as a therapeutic target for radiation sensitization in lung cancer Cancer Res 2004, 64(8):2840-2845 10.1158/ 0008-5472.CAN-03-3547 15087401
3. Altieri DC Marchisio PC Survivin apoptosis: An interloper between cell death and cell proliferation in cancer Lab Invest 1999, 79(11):1327-1333 10576203
4. Tu SP Jiang XH Lin MC Cui JT Yang Y Lum CT Zou B Zhu YB Jiang SH Wong WM Chan AO Yuen MF Lam SK Kung HF Wong BC Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer Cancer Res 2003, 63(22):7724-7732 14633697
5. Kawasaki H Toyoda M Shinohara H Okuda J Watanabe I Yamamoto T Tanaka K Tenjo T Tanigawa N Expression of survivin correlates with apoptosis, proliferation, and angiogenesis during human colorectal tumorigenesis Cancer 2001, 91(11):2026-2032 10.1002/ 1097-0142(20010601)91:11<2026::AID-CNCR1228>3.0.CO;2-E 11391581
6. Kato J Kuwabara Y Mitani M Shinoda N Sato A Toyama T Mitsui A Nishiwaki T Moriyama S Kudo J Fujii Y Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy Int J Cancer 2001, 95(2):92-95 10.1002/ 1097-0215(20010320)95:2<92::AID-IJC1016>3.0.CO;2-9 11241318
7. Cohen C Lohmann CM Cotsonis G Lawson D Santoianni R Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis Mod Pathol 2003, 16(6):574-583 10.1097/01.MP.0000073868.31297.B0 12808063
8. Dong Y Sui L Watanabe Y Sugimoto K Tokuda M Survivin expression in laryngeal squamous cell carcinomas and its prognostic implications Anticancer Res 2002, 22(4):2377-2383 12174930
9. Tanaka K Iwamoto S Gon G Nohara T Iwamoto M Tanigawa N Expression of survivin and its relationship to loss of apoptosis in breast carcinomas Clin Cancer Res 2000, 6(1):127-134 10656440
10. Schlette EJ Medeiros LJ Goy A Lai R Rassidakis GZ Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma J Clin Oncol 2004, 22(9):1682-1688 10.1200/JCO.2004.10.172 15117990
11. Kappler M Kotzsch M Bartel F Fussel S Lautenschlager C Schmidt U Wurl P Bache M Schmidt H Taubert H Meye A Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival Clin Cancer Res 2003, 9(3):1098-1104 12631613
12. Kawasaki H Altieri DC Lu CD Toyoda M Tenjo T Tanigawa N Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res 1998, 58(22):5071-5074 9823313
13. Ferrara N Gerber HP LeCouter J The biology of VEGF and its receptors Nat Med 2003, 9(6):669-676 10.1038/nm0603-669 12778165
14. Wakisaka N Wen QH Yoshizaki T Nishimura T Furukawa M Kawahara E Nakanishi I Association of vascular endothelial growth factor expression with angiogenesis and lymph node metastasis in nasopharyngeal carcinoma Laryngoscope 1999, 109(5):810-814 10.1097/00005537-199905000-00024 10334236
15. Polverini PJ Leibovich SJ Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages Lab Invest 1984, 51(6):635-642 6209469
16. Plate KH Breier G Weich HA Risau W Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Nature 1992, 359(6398):845-848 10.1038/359845a0 1279432
17. Toi M Matsumoto T Bando H Vascular endothelial growth factor: Its prognostic, predictive, and therapeutic implications Lancet Oncol 2001, 2(11):667-673 10.1016/S1470-2045(01)00556-3 11902537
18. Ferrara N VEGF and the quest for tumour angiogenesis factors Nat Rev Cancer 2002, 2(10):795-803 10.1038/nrc909 12360282
19. Celen O Kahraman I Yildirim E Berberoglu U Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients Neoplasma 2004, 51(4):293-299 15254661
20. Jin Q Hemminki K Enquist K Lenner P Grzybowska E Klaes R Henriksson R Chen B Pamula J Pekala W Zientek H Rogozinska-Szczepka J Utracka-Hutka B Hallmans G Forsti A Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis Clin Cancer Res 2005, 11(10):3647-3653 10.1158/1078-0432.CCR-04-1803 15897560
21. Smith BD Smith GL Carter D Sasaki CT Haffty BG Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma J Clin Oncol 2000, 18(10):2046-2052 10811669
22. Koukourakis MI Papazoglou D Giatromanolaki A Bougioukas G Maltezos E Sivridis E VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer Lung Cancer 2004, 46(3):293-298 10.1016/j.lungcan.2004.04.037 15541813
23. Licitra L Bernier J Cvitkovic E Grandi C Spinazze S Bruzzi P Gatta G Molinari R Cancer of the nasopharynx Crit Rev Oncol Hematol 2003, 45(2):199-213 10.1016/S1040-8428(01)00210-4 12604130
24. Titcomb CP Jr. High incidence of nasopharyngeal carcinoma in Asia J Insur Med 2001, 33(3):235-238 11558403
25. Farias TP Dias FL Lima RA Kligerman J de Sa GM Barbosa MM Goncalves FB Jr. Prognostic factors and outcome for nasopharyngeal carcinoma Arch Otolaryngol Head Neck Surg 2003, 129(7):794-799 10.1001/ archotol.129.7.794 12874084
26. Tatsumi-Tamori A Yoshizaki T Miwa T Furukawa M Clinical evaluation of staging system for nasopharyngeal carcinoma: Comparison of fourth and fifth editions of UICC TNM classification Ann Otol Rhinol Laryngol 2000, 109(12 Pt 1):1125-1129 11130824
27. Hong MH Mai HQ Min HQ Ma J Zhang EP Cui NJ A comparison of the Chinese 1992 and fifth-edition International Union Against Cancer staging systems for staging nasopharyngeal carcinoma Cancer 2000, 89(2):242-247 10.1002/1097-0142(20000715)89:2<242::AID-CNCR6>3.0.CO;2-Z 10918151
28. Heng DM Wee J Fong KW Lian LG Sethi VK Chua ET Yang TL Khoo Tan HS Lee KS Lee KM Tan T Chua EJ Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma Cancer 1999, 86(10):1912-1920 10.1002/ (SICI)1097-0142(19991115)86:10<1912::AID-CNCR6>3.0.CO;2-S 10570413
29. Sakata K Hareyama M Tamakawa M Oouchi A Sido M Nagakura H Akiba H Koito K Himi T Asakura K Prognostic factors of nasopharynx tumors investigated by MR imaging and the value of MR imaging in the newly published TNM staging Int J Radiat Oncol Biol Phys 1999, 43(2):273-278 10.1016/ S0360-3016(98)00417-9 10030249
30. Min H HM Ma J, et al A new staging system for nasopharyngeal carcinoma in China Int J Radiat Oncol Biol Phys 1994, 30:1037-1042 7961009
31. Lo Muzio L Pannone G Staibano S Mignogna MD Rubini C Mariggio MA Procaccini M Ferrari F De Rosa G Altieri DC Survivin expression in oral squamous cell carcinoma Br J Cancer 2003, 89(12):2244-2248 10.1038/ sj.bjc.6601402 14676801
32. Shao JY Ernberg I Biberfeld P Heiden T Zeng YX Hu LF Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma Anticancer Res 2004, 24(4):2309-2318 15330177
33. Swana HS Grossman D Anthony JN Weiss RM Altieri DC Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer N Engl J Med 1999, 341(6):452-453 10.1056/NEJM199908053410614 10438269
34. Xiang Y Yao H Wang S Hong M He J Cao S Min H Song E Guo X Prognostic value of Survivin and Livin in nasopharyngeal carcinoma Laryngoscope 2006, 116(1):126-130 10.1097/01.mlg.0000187392.87904.35 16481824
35. Yip KW Shi W Pintilie M Martin JD Mocanu JD Wong D MacMillan C Gullane P O'Sullivan B Bastianutto C Liu FF Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer Clin Cancer Res 2006, 12(19):5726-5732 10.1158/1078-0432.CCR-06-0571 17020977
36. Folkman J The role of angiogenesis in tumor growth Semin Cancer Biol 1992, 3(2):65-71 1378311
37. Nakayama Y Sako T Shibao K Okazaki K Rempo N Onitsuka K Minagawa N Akahane K Nagashima N Nagata N Itoh H Prognostic value of plasma vascular endothelial growth factor in patients with colorectal cancer Anticancer Res 2002, 22(4):2437-2442 12174940
38. Desruisseau S Palmari J Giusti C Romain S Martin PM Berthois Y Clinical relevance of amphiregulin and VEGF in primary breast cancers Int J Cancer 2004, 111(5):733-740 10.1002/ijc.20312 15252843
39. Do NY Lim SC Im TS Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck Oncol Rep 2004, 12(2):229-237 15254682
40. Guang-Wu H Sunagawa M Jie-En L Shimada S Gang Z Tokeshi Y Kosugi T The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma Laryngoscope 2000, 110(12):2066-2069 10.1097/ 00005537-200012000-00017 11129022
41. Sauter ER NM Watson JC, et al. [J]. Clin Cancer Res, 1999, 5(4):775-782. Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck Clin Cancer Res 1999, 5(4):775-782 10213212
42. Qian CN Zhang CQ Guo X Hong MH Cao SM Mai WY Min HQ Zeng YX Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma Cancer 2000, 88(2):255-261 10.1002/ (SICI)1097-0142(20000115)88:2<255::AID-CNCR2>3.0.CO;2-N 10640954
43. Li YH Shao JY Li S Zou BY Huang HQ Guan ZZ [Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma] Ai Zheng 2004, 23(9):1060-1064 15363202
44. Zhao SP Wang CL [Expression and clinical significance of vascular endothelial growth factor in nasopharyngeal carcinoma] Hunan Yi Ke Da Xue Xue Bao 2003, 28(2):114-116 12934350
45. Jiang WZ Liao YP Zhao SP Wu HJ [Expression clinical significance of nm23-H1 and vessel endothelium growth factor protein in nasopharyngeal carcinoma] Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2006, 41(3):200-204 16759016
46. Sha D He YJ [Expression and clinical significance of VEGF and its receptors Flt-1 and KDR in nasopharyngeal carcinoma] Ai Zheng 2006, 25(2):229-234 16480593
47. Krishna SM James S Balaram P Expression of VEGF as prognosticator in primary nasopharyngeal cancer and its relation to EBV status Virus Res 2006, 115(1):85-90 10.1016/j.virusres.2005.07.010 16139912
48. Beierle EA Nagaram A Dai W Iyengar M Chen MK VEGF-mediated survivin expression in neuroblastoma cells J Surg Res 2005, 127(1):21-28 10.1016/ j.jss.2005.03.009 15882878
49. Murono S Inoue H Tanabe T Joab I Yoshizaki T Furukawa M Pagano JS Induction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells Proc Natl Acad Sci U S A 2001, 98(12):6905-6910 34451 11381123 10.1073/pnas.121016998
50. Stevenson D Charalambous C Wilson JB Epstein-Barr virus latent membrane protein 1 (CAO) up-regulates VEGF and TGF alpha concomitant with hyperlasia, with subsequent up-regulation of p16 and MMP9 Cancer Res 2005, 65(19):8826-8835 10.1158/0008-5472.CAN-05-0591 16204053
51. O'Connor DS Schechner JS Adida C Mesri M Rothermel AL Li F Nath AK Pober JS Altieri DC Control of apoptosis during angiogenesis by survivin expression in endothelial cells Am J Pathol 2000, 156(2):393-398 1850029 10666367